Copyright Reports & Markets. All rights reserved.

Global Opioid Receptor Agonist Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Opioid Receptor Agonist Market Status and Forecast (2017-2028)
      • 1.3.2 Global Opioid Receptor Agonist Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Opioid Receptor Agonist Supply by Company

    • 2.1 Global Opioid Receptor Agonist Sales Volume by Company
    • 2.2 Global Opioid Receptor Agonist Sales Value by Company
    • 2.3 Global Opioid Receptor Agonist Price by Company
    • 2.4 Opioid Receptor Agonist Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Opioid Receptor Agonist Market Status by Type

    • 3.1 Opioid Receptor Agonist Type Introduction
      • 3.1.1 Fentanyl
      • 3.1.2 Codeine
      • 3.1.3 Morphine
      • 3.1.4 Others
    • 3.2 Global Opioid Receptor Agonist Market by Type
      • 3.2.1 Global Opioid Receptor Agonist Sales Volume by Type (2017-2022)
      • 3.2.2 Global Opioid Receptor Agonist Sales Value by Type (2017-2022)
      • 3.2.3 Global Opioid Receptor Agonist Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Opioid Receptor Agonist Market Status by Application

    • 4.1 Opioid Receptor Agonist Segment by Application
      • 4.1.1 Hospital Pharmacy
      • 4.1.2 Online Pharmacy
      • 4.1.3 Retail Pharmacy
    • 4.2 Global Opioid Receptor Agonist Market by Application
      • 4.2.1 Global Opioid Receptor Agonist Sales Volume by Application (2017-2022)
      • 4.2.2 Global Opioid Receptor Agonist Sales Value by Application (2017-2022)
      • 4.2.3 Global Opioid Receptor Agonist Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Opioid Receptor Agonist Market Status by Region

    • 5.1 Global Opioid Receptor Agonist Market by Region
      • 5.1.1 Global Opioid Receptor Agonist Sales Volume by Region
      • 5.1.2 Global Opioid Receptor Agonist Sales Value by Region
    • 5.2 North America Opioid Receptor Agonist Market Status
    • 5.3 Europe Opioid Receptor Agonist Market Status
    • 5.4 Asia Pacific Opioid Receptor Agonist Market Status
    • 5.5 Central & South America Opioid Receptor Agonist Market Status
    • 5.6 Middle East & Africa Opioid Receptor Agonist Market Status

    6 North America Opioid Receptor Agonist Market Status

    • 6.1 North America Opioid Receptor Agonist Market by Country
      • 6.1.1 North America Opioid Receptor Agonist Sales Volume by Country (2017-2022)
      • 6.1.2 North America Opioid Receptor Agonist Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Opioid Receptor Agonist Market Status

    • 7.1 Europe Opioid Receptor Agonist Market by Country
      • 7.1.1 Europe Opioid Receptor Agonist Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Opioid Receptor Agonist Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Opioid Receptor Agonist Market Status

    • 8.1 Asia Pacific Opioid Receptor Agonist Market by Country
      • 8.1.1 Asia Pacific Opioid Receptor Agonist Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Opioid Receptor Agonist Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Opioid Receptor Agonist Market Status

    • 9.1 Central & South America Opioid Receptor Agonist Market by Country
      • 9.1.1 Central & South America Opioid Receptor Agonist Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Opioid Receptor Agonist Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Opioid Receptor Agonist Market Status

    • 10.1 Middle East & Africa Opioid Receptor Agonist Market by Country
      • 10.1.1 Middle East & Africa Opioid Receptor Agonist Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Opioid Receptor Agonist Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Opioid Receptor Agonist Manufacturing Cost Analysis
    • 11.5 Opioid Receptor Agonist Sales Channel and Distributors Analysis
      • 11.5.1 Opioid Receptor Agonist Sales Channel
      • 11.5.2 Opioid Receptor Agonist Distributors
    • 11.6 Opioid Receptor Agonist Downstream Major Buyers

    12 Global Opioid Receptor Agonist Market Forecast by Type and by Application

    • 12.1 Global Opioid Receptor Agonist Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Opioid Receptor Agonist Forecast by Type
      • 12.2.1 Global Opioid Receptor Agonist Sales Volume Forecast by Type
      • 12.2.2 Global Opioid Receptor Agonist Sales Value Forecast by Type
      • 12.2.3 Global Opioid Receptor Agonist Price Forecast by Type
    • 12.3 Global Opioid Receptor Agonist Forecast by Application
      • 12.3.1 Global Opioid Receptor Agonist Sales Volume Forecast by Application
      • 12.3.2 Global Opioid Receptor Agonist Sales Value Forecast by Application
      • 12.3.3 Global Opioid Receptor Agonist Price Forecast by Application

    13 Global Opioid Receptor Agonist Market Forecast by Region/Country

    • 13.1 Global Opioid Receptor Agonist Market Forecast by Region (2023-2028)
      • 13.1.1 Global Opioid Receptor Agonist Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Opioid Receptor Agonist Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 US WorldMeds
      • 14.1.1 Company Information
      • 14.1.2 Opioid Receptor Agonist Product Introduction
      • 14.1.3 US WorldMeds Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Tris Pharma
      • 14.2.1 Company Information
      • 14.2.2 Opioid Receptor Agonist Product Introduction
      • 14.2.3 Tris Pharma Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Teva Pharmaceutical Industries
      • 14.3.1 Company Information
      • 14.3.2 Opioid Receptor Agonist Product Introduction
      • 14.3.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Sun Pharmaceutical Industries
      • 14.4.1 Company Information
      • 14.4.2 Opioid Receptor Agonist Product Introduction
      • 14.4.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Purdue Pharma
      • 14.5.1 Company Information
      • 14.5.2 Opioid Receptor Agonist Product Introduction
      • 14.5.3 Purdue Pharma Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Piramal Critical Care
      • 14.6.1 Company Information
      • 14.6.2 Opioid Receptor Agonist Product Introduction
      • 14.6.3 Piramal Critical Care Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Pfizer
      • 14.7.1 Company Information
      • 14.7.2 Opioid Receptor Agonist Product Introduction
      • 14.7.3 Pfizer Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Mylan N.V.
      • 14.8.1 Company Information
      • 14.8.2 Opioid Receptor Agonist Product Introduction
      • 14.8.3 Mylan N.V. Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Johnson & Johnson
      • 14.9.1 Company Information
      • 14.9.2 Opioid Receptor Agonist Product Introduction
      • 14.9.3 Johnson & Johnson Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Indivior
      • 14.10.1 Company Information
      • 14.10.2 Opioid Receptor Agonist Product Introduction
      • 14.10.3 Indivior Opioid Receptor Agonist Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Hikma Pharmaceuticals
    • 14.12 Fresenius Kabi
    • 14.13 Endo Pharmaceuticals
    • 14.14 DAIICHI SANKYO COMPANY
    • 14.15 Allergan

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Opioid Receptor Agonist market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Opioid Receptor Agonist industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Opioid Receptor Agonist market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Opioid Receptor Agonist Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Opioid Receptor Agonist market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Opioid Receptor Agonist Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Opioid Receptor Agonist industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Fentanyl
      Codeine

      Segmented by Application
      Hospital Pharmacy
      Online Pharmacy
      Retail Pharmacy

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teva Pharmaceutical Industries
      Sun Pharmaceutical Industries
      Purdue Pharma
      Piramal Critical Care
      Pfizer
      Mylan N.V.
      Johnson & Johnson
      Indivior
      Hikma Pharmaceuticals
      Fresenius Kabi
      Endo Pharmaceuticals
      DAIICHI SANKYO COMPANY
      Allergan
      Buy now